An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination
•-An old woman developed interstitial pneumonia after mRNA-1273 vaccination.•-The patient's symptoms, laboratory findings, and images were similar to those of COVID-19.•-Serological and pathological tests were useful in diagnosing vaccine-induced acute respiratory distress syndrome.•-Serum leve...
Saved in:
| Published in | International Journal of Infectious Diseases Vol. 121; pp. 98 - 101 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Canada
Elsevier Ltd
01.08.2022
Elsevier BV The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •-An old woman developed interstitial pneumonia after mRNA-1273 vaccination.•-The patient's symptoms, laboratory findings, and images were similar to those of COVID-19.•-Serological and pathological tests were useful in diagnosing vaccine-induced acute respiratory distress syndrome.•-Serum level of antibodies against spike protein was extremely high.
We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19. |
|---|---|
| AbstractList | We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19. •-An old woman developed interstitial pneumonia after mRNA-1273 vaccination.•-The patient's symptoms, laboratory findings, and images were similar to those of COVID-19.•-Serological and pathological tests were useful in diagnosing vaccine-induced acute respiratory distress syndrome.•-Serum level of antibodies against spike protein was extremely high. We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19. We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19.We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19. |
| Author | Ryo, Akihide Maeda, Kazuho Iwashita, Hiromichi Sasaki, Hiroaki Miyata, Nobuyuki Hatayama, Yasuyoshi Miyazaki, Kazuhito Hayashi, Hiroyuki Kawana-Tachikawa, Ai Tachikawa, Natsuo Okudela, Koji Tateishi, Yoko Ihama, Yoko Yoshimura, Yukihiro |
| Author_xml | – sequence: 1 givenname: Yukihiro orcidid: 0000-0002-5046-7819 surname: Yoshimura fullname: Yoshimura, Yukihiro email: yymole@gmail.com organization: Department of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama city, Japan – sequence: 2 givenname: Hiroaki orcidid: 0000-0003-3414-1146 surname: Sasaki fullname: Sasaki, Hiroaki organization: Department of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama city, Japan – sequence: 3 givenname: Nobuyuki surname: Miyata fullname: Miyata, Nobuyuki organization: Department of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama city, Japan – sequence: 4 givenname: Kazuhito surname: Miyazaki fullname: Miyazaki, Kazuhito organization: Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, Yokohama city, Japan – sequence: 5 givenname: Koji surname: Okudela fullname: Okudela, Koji organization: Department of Pathology Yokohama City University Graduate School of Medicine, Yokohama city, Japan – sequence: 6 givenname: Yoko surname: Tateishi fullname: Tateishi, Yoko organization: Department of Pathology, Yokohama Municipal Citizen's Hospital, Yokohama city, Japan – sequence: 7 givenname: Hiroyuki surname: Hayashi fullname: Hayashi, Hiroyuki organization: Department of Pathology, Yokohama Municipal Citizen's Hospital, Yokohama city, Japan – sequence: 8 givenname: Ai orcidid: 0000-0002-3082-5324 surname: Kawana-Tachikawa fullname: Kawana-Tachikawa, Ai organization: AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 9 givenname: Hiromichi surname: Iwashita fullname: Iwashita, Hiromichi organization: Department of Pathology Yokohama City University Graduate School of Medicine, Yokohama city, Japan – sequence: 10 givenname: Kazuho surname: Maeda fullname: Maeda, Kazuho organization: Department of Legal Medicine, Yokohama City University Graduate School of Medicine, Yokohama city, Japan – sequence: 11 givenname: Yoko surname: Ihama fullname: Ihama, Yoko organization: Department of Legal Medicine, Yokohama City University Graduate School of Medicine, Yokohama city, Japan – sequence: 12 givenname: Yasuyoshi surname: Hatayama fullname: Hatayama, Yasuyoshi organization: Department of Microbiology, Yokohama City University School of Medicine, Yokohama city, Japan – sequence: 13 givenname: Akihide surname: Ryo fullname: Ryo, Akihide organization: Department of Microbiology, Yokohama City University School of Medicine, Yokohama city, Japan – sequence: 14 givenname: Natsuo surname: Tachikawa fullname: Tachikawa, Natsuo organization: Department of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama city, Japan |
| BackLink | https://cir.nii.ac.jp/crid/1873116917887508992$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/35500794$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUstuEzEUHaEi2gZ-gAWaBQs2M1zbM_YYIaQovCJVVGqrbi3HvilOJuPUdiLl73GaFtEuysbP87i-PqfF0eAHLIq3BGoChH9c1G7hbE2B0hqaGlrxojghnegq1hJylNcUSCUFocfFaYwLAGg4714Vx6xtAYRsTorleCj1Jvl13JVGRyz9vJycX0-_VkRWvVtiqc0mYRkwrl3QyYddaV1MeR_LuBts8KuMmScM5eri17giVLDycnxxWU38dUXLrTbGDTo5P7wuXs51H_HN_Twqrr5_u5r8rM7Of0wn47PKcC5SZVvsZhSREaSNzK-SlgPTXDetAGMkb2SjBQiGgACWW0EIscwSLRDBsFExPcharxdqHdxKh53y2qm7Ax9ulA7JmR6V5Jko2YyQljfUNB3OGJWWoCXUmm6etb4ctNab2QqtwSEF3T8SfXwzuN_qxm9VrrsRwLPAh3uB4G83GJNauWiw7_WAfhMV5a2kDCjrMvTdv15_TR4-KwO6A8AEH2PAuTIu3XU2W7teEVD7XKiF2udC7XOhoFG5g5lKn1Af1J8lvT-QBuey1X7M6WKEcElE14kWOpmLHxWfDzDMf7p1GFQ0DgeD1gU0KXfdPe_y6Qnd9NnL6H6Ju_-R_wAWbO0I |
| CitedBy_id | crossref_primary_10_1111_jdv_19401 crossref_primary_10_32604_biocell_2023_029379 crossref_primary_10_1007_s40278_022_18450_2 crossref_primary_10_3390_biomedicines11082113 crossref_primary_10_7759_cureus_70370 crossref_primary_10_1016_j_forsciint_2024_112115 crossref_primary_10_3390_jcm13237291 crossref_primary_10_3346_jkms_2023_38_e106 |
| Cites_doi | 10.1056/NEJMoa2034577 10.3390/diagnostics11060955 10.1016/j.jiac.2021.08.008 10.1016/j.cell.2020.09.038 10.3390/jcm10245876 10.1038/s41591-021-01583-4 10.1016/j.vaccine.2021.01.053 10.1016/j.jiac.2021.09.010 10.1056/NEJMoa2035389 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. 2022 The Authors 2022 |
| Copyright_xml | – notice: 2022 The Authors – notice: Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: 2022 The Authors 2022 |
| DBID | 6I. AAFTH RYH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.ijid.2022.04.057 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CiNii Complete CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1878-3511 |
| EndPage | 101 |
| ExternalDocumentID | oai_doaj_org_article_961d393b115642c48eb329d1ed12dc8f PMC9054706 35500794 10_1016_j_ijid_2022_04_057 S1201971222002570 |
| Genre | Case Reports |
| GroupedDBID | --- --K .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29J 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 7X7 88E 8C1 8FI 8FJ 8FQ 8R4 8R5 AAEDW AAFWJ AAIKJ AALRI AAQFI AAQXK AARKO AAXUO AAYWO ABBQC ABFRF ABMAC ABUWG ABWVN ACGFO ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFJKZ AFKRA AFPKN AFPUW AFRHN AFTJW AGEKW AGHFR AGQPQ AGYEJ AHMBA AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL BCNDV BENPR BPHCQ BR6 BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU FYUFA G-Q GBLVA GROUPED_DOAJ GX1 HMCUK HVGLF HZ~ IHE IXB J1W KQ8 M1P M3C M3G M41 MO0 N9A O-L O9- OD- OK1 OO. OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q2X Q38 QTD R2- ROL RPZ RWL RXW SDF SDG SEL SES SEW SSZ TAE UKHRP UNMZH Z5R 0SF 3V. 6I. AACTN AAFTH ABVKL AFCTW NCXOZ RIG ALIPV RYH AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c667t-d5e8b2ee31e2490579d603a6a4570cc96494a7073e0e00d6d7111d3d1a7ee0c3 |
| IEDL.DBID | DOA |
| ISSN | 1201-9712 1878-3511 |
| IngestDate | Wed Aug 27 01:23:39 EDT 2025 Thu Aug 21 14:33:47 EDT 2025 Thu Jul 10 21:59:21 EDT 2025 Mon Jul 21 06:02:36 EDT 2025 Tue Jul 01 04:30:13 EDT 2025 Thu Apr 24 23:04:54 EDT 2025 Thu Jun 26 23:06:41 EDT 2025 Fri Feb 23 02:40:44 EST 2024 Tue Aug 26 16:32:08 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | COVID-19 acute respiratory distress syndrome vaccine autopsy |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c667t-d5e8b2ee31e2490579d603a6a4570cc96494a7073e0e00d6d7111d3d1a7ee0c3 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| ORCID | 0000-0003-3414-1146 0000-0002-3082-5324 0000-0002-5046-7819 0000-0002-0079-2883 |
| OpenAccessLink | https://doaj.org/article/961d393b115642c48eb329d1ed12dc8f |
| PMID | 35500794 |
| PQID | 2659230238 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_961d393b115642c48eb329d1ed12dc8f pubmedcentral_primary_oai_pubmedcentral_nih_gov_9054706 proquest_miscellaneous_2659230238 pubmed_primary_35500794 crossref_citationtrail_10_1016_j_ijid_2022_04_057 crossref_primary_10_1016_j_ijid_2022_04_057 nii_cinii_1873116917887508992 elsevier_sciencedirect_doi_10_1016_j_ijid_2022_04_057 elsevier_clinicalkey_doi_10_1016_j_ijid_2022_04_057 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-08-01 |
| PublicationDateYYYYMMDD | 2022-08-01 |
| PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Canada |
| PublicationPlace_xml | – name: Canada |
| PublicationTitle | International Journal of Infectious Diseases |
| PublicationTitleAlternate | Int J Infect Dis |
| PublicationYear | 2022 |
| Publisher | Elsevier Ltd Elsevier BV The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier BV – name: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases – name: Elsevier |
| References | Ministry of Health, Labour and Welfare of Japan. Possible adverse events report of COVID-19 vaccines (in Japanese) Pomara, Sessa, Ciaccio, Dieli, Esposito, Giammanco (bib0006) 2021; 11 Yoshifuji, Ishioka, Masuzawa, Suda, Murata, Uwamino (bib0013) 2022; 28 Baden, El Sahly, Essink, Kotloff, Frey, Novak (bib0002) 2021; 384 Tang, Hasan, Chemaitelly, Yassine, Benslimane, Al Khatib (bib0011) 2021; 27 (accessed 16 April 2022). Yoshimura, Sasaki, Miyata, Miyazaki, Tachikawa (bib0014) 2021; 27 Ranieri, Rubenfeld, Thompson, Ferguson, Caldwell, Fan (bib0001) 2012; 307 Serazin, Edem, Williams, Ortiz, Kawade, Das (bib0009) 2021; 39 (accessed 4 November 2021 ). Park, Kim, Lee, Kim, Park, Hwang (bib0004) 2022; 77 Rydyznski Moderbacher, Ramirez, Dan, Grifoni, Hastie, Weiskopf (bib0008) 2020; 183 Sessa, Salerno, Esposito, Di Nunno, Zamboni, Pomara (bib0010) 2021; 10 Prime Minister's Office of Japan. Novel coronavirus vaccines Polack, Thomas, Kitchin, Absalon, Gurtman, Lockhart (bib0005) 2020; 383 World Health Organization. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification second edition, 2019 update 10.1016/j.ijid.2022.04.057_bib0007 Baden (10.1016/j.ijid.2022.04.057_bib0002) 2021; 384 Pomara (10.1016/j.ijid.2022.04.057_bib0006) 2021; 11 Tang (10.1016/j.ijid.2022.04.057_bib0011) 2021; 27 Serazin (10.1016/j.ijid.2022.04.057_bib0009) 2021; 39 10.1016/j.ijid.2022.04.057_bib0012 10.1016/j.ijid.2022.04.057_bib0003 Park (10.1016/j.ijid.2022.04.057_bib0004) 2022; 77 Ranieri (10.1016/j.ijid.2022.04.057_bib0001) 2012; 307 Rydyznski Moderbacher (10.1016/j.ijid.2022.04.057_bib0008) 2020; 183 Sessa (10.1016/j.ijid.2022.04.057_bib0010) 2021; 10 Yoshifuji (10.1016/j.ijid.2022.04.057_bib0013) 2022; 28 Yoshimura (10.1016/j.ijid.2022.04.057_bib0014) 2021; 27 Polack (10.1016/j.ijid.2022.04.057_bib0005) 2020; 383 |
| References_xml | – volume: 27 start-page: 2136 year: 2021 end-page: 2143 ident: bib0011 article-title: BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar publication-title: Nat Med – reference: ; (accessed 4 November 2021 ). – volume: 383 start-page: 2603 year: 2020 end-page: 2615 ident: bib0005 article-title: Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine publication-title: N Engl J Med – reference: Ministry of Health, Labour and Welfare of Japan. Possible adverse events report of COVID-19 vaccines (in Japanese), – reference: ; (accessed 16 April 2022). – volume: 183 start-page: 996 year: 2020 end-page: 1012 ident: bib0008 article-title: Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity publication-title: Cell – volume: 77 start-page: 102 year: 2022 end-page: 104 ident: bib0004 article-title: COVID-19 vaccine-related interstitial lung disease: a case study publication-title: Thorax;thoraxjnl-2021-217609 – reference: Prime Minister's Office of Japan. Novel coronavirus vaccines, – volume: 27 start-page: 1713 year: 2021 end-page: 1715 ident: bib0014 article-title: Antibody response after COVID-19 vaccine BNT162b2 on health care workers in Japan publication-title: J Infect Chemother – volume: 39 start-page: 3028 year: 2021 end-page: 3036 ident: bib0009 article-title: Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: case definition & guidelines for data collection, analysis, and presentation of immunization safety data publication-title: Vaccine – volume: 28 start-page: 95 year: 2022 end-page: 98 ident: bib0013 article-title: COVID-19 vaccine induced interstitial lung disease publication-title: J Infect Chemother – volume: 307 start-page: 2526 year: 2012 end-page: 2533 ident: bib0001 article-title: Acute respiratory distress syndrome: the Berlin Definition publication-title: JAMA – volume: 384 start-page: 403 year: 2021 end-page: 416 ident: bib0002 article-title: Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine publication-title: N Engl J Med – volume: 11 start-page: 955 year: 2021 ident: bib0006 article-title: COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis publication-title: Diagnostics (Basel) – volume: 10 start-page: 5876 year: 2021 ident: bib0010 article-title: Autopsy findings and causality relationship between death and COVID-19 vaccination: A systematic review publication-title: J Clin Med – reference: World Health Organization. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification second edition, 2019 update, – volume: 383 start-page: 2603 year: 2020 ident: 10.1016/j.ijid.2022.04.057_bib0005 article-title: Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine publication-title: N Engl J Med doi: 10.1056/NEJMoa2034577 – volume: 11 start-page: 955 year: 2021 ident: 10.1016/j.ijid.2022.04.057_bib0006 article-title: COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis publication-title: Diagnostics (Basel) doi: 10.3390/diagnostics11060955 – ident: 10.1016/j.ijid.2022.04.057_bib0007 – volume: 27 start-page: 1713 year: 2021 ident: 10.1016/j.ijid.2022.04.057_bib0014 article-title: Antibody response after COVID-19 vaccine BNT162b2 on health care workers in Japan publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.08.008 – ident: 10.1016/j.ijid.2022.04.057_bib0012 – volume: 183 start-page: 996 year: 2020 ident: 10.1016/j.ijid.2022.04.057_bib0008 article-title: Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity publication-title: Cell doi: 10.1016/j.cell.2020.09.038 – volume: 10 start-page: 5876 year: 2021 ident: 10.1016/j.ijid.2022.04.057_bib0010 article-title: Autopsy findings and causality relationship between death and COVID-19 vaccination: A systematic review publication-title: J Clin Med doi: 10.3390/jcm10245876 – volume: 307 start-page: 2526 year: 2012 ident: 10.1016/j.ijid.2022.04.057_bib0001 article-title: Acute respiratory distress syndrome: the Berlin Definition publication-title: JAMA – ident: 10.1016/j.ijid.2022.04.057_bib0003 – volume: 27 start-page: 2136 year: 2021 ident: 10.1016/j.ijid.2022.04.057_bib0011 article-title: BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar publication-title: Nat Med doi: 10.1038/s41591-021-01583-4 – volume: 39 start-page: 3028 year: 2021 ident: 10.1016/j.ijid.2022.04.057_bib0009 article-title: Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: case definition & guidelines for data collection, analysis, and presentation of immunization safety data publication-title: Vaccine doi: 10.1016/j.vaccine.2021.01.053 – volume: 28 start-page: 95 year: 2022 ident: 10.1016/j.ijid.2022.04.057_bib0013 article-title: COVID-19 vaccine induced interstitial lung disease publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.09.010 – volume: 384 start-page: 403 year: 2021 ident: 10.1016/j.ijid.2022.04.057_bib0002 article-title: Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine publication-title: N Engl J Med doi: 10.1056/NEJMoa2035389 – volume: 77 start-page: 102 year: 2022 ident: 10.1016/j.ijid.2022.04.057_bib0004 article-title: COVID-19 vaccine-related interstitial lung disease: a case study publication-title: Thorax;thoraxjnl-2021-217609 |
| SSID | ssj0004668 ssib030784372 ssib044741017 |
| Score | 2.3538463 |
| Snippet | •-An old woman developed interstitial pneumonia after mRNA-1273 vaccination.•-The patient's symptoms, laboratory findings, and images were similar to those of... We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea... |
| SourceID | doaj pubmedcentral proquest pubmed crossref nii elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 98 |
| SubjectTerms | acute respiratory distress syndrome autopsy COVID-19 Infectious and parasitic diseases RC109-216 vaccine |
| SummonAdditionalLinks | – databaseName: ScienceDirect Free and Delayed Access Titles dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGHhASQjC-MhgyEm_Iqp04dvLYFaaBxJDWMfXNcmx3ZBtJ1aWT-O-5y0dpERoSL5Wa2o1zvtzvkrv7HSHvRKZdNk85E3peMImN3DMAOsYDYEthwSEp2gTZE3X8TX6epbMdMhlqYTCtsrf9nU1vrXV_ZNRLc7Qoy9FUAHblWgDAIXBrfG5PZNYW8c0ON2oju3I4GMxwdF840-V4lZclsoXGcUt3ihC1AU4th_8WRt2ryvJvnuifCZUbCHX0mDzqXUs67lb_hOyEao_c_9IHz_fIw-4VHe0qj56Sq3FF7aqpFzc_qQMwo_WcTr6ef_rARM6uy6tArVs1gS5_R-OpL7viEjowHdC2yTj9cXoyZgKcFDodn07ZpD5nMb21Ds7cbv0zcnb08WxyzPreC8wppRvm05AVcQiJCPCAhhWrXvHEKitB0s7lSubSarAPgQfOvfIajKZPvLA6BO6S52S3qqvwklBrwQkIaeY0eg-W55bP86A8WHyrsjxERAwyN67nJcf2GNdmSEC7NLhPBvfJcGlgMRF5v56z6Fg57hx9iFu5HomM2u2BenlhepUyuYLlg3oKZM-JncxCkcS5F8GL2IM6RyQZFMEMRatgZuGPyjtPna5nban1P-cdgK6BPPAT7qdEIKkRZn6mGKeNI_J20EID9gCDPLYK9erGxBgnx05QWURedFq5vnDwLcElzGVE9Ja-bklm-5eq_N5yjoMKSM3V_n9ezyvyAL91mZOvyW6zXIUD8Oaa4k17u_4CEKJBXw priority: 102 providerName: Elsevier |
| Title | An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1201971222002570 https://dx.doi.org/10.1016/j.ijid.2022.04.057 https://cir.nii.ac.jp/crid/1873116917887508992 https://www.ncbi.nlm.nih.gov/pubmed/35500794 https://www.proquest.com/docview/2659230238 https://pubmed.ncbi.nlm.nih.gov/PMC9054706 https://doaj.org/article/961d393b115642c48eb329d1ed12dc8f |
| Volume | 121 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZoDwgJISivAK2MxA0Z7Dzs5LhdWrVILVJbqr1Zju1V05akarNIXPrbmYmTsItQe-HiwyaOY3sy33hn5htCPohc2XyecSbUvGQpFnLPAegY94AtpQGDpOwCZA_l3vf06yybLZX6wpiwQA8cFu5zIYVLoJtAVpPYpjmc_uLCCe9E7GAY1L6AecNhasyIDElwAG-sUCLu02VCZFd1XiFHaBx3JKcITEuQ1DH3ryDTWl1V_7I__w6jXMKl3afkSW9Q0kmYyDPywNcb5OFB7zLfII_DH3M05Bs9JxeTmppF21zd_KIWIIw2czr9drr_hYmCXVYXnhq7aD29_uODp64KKSV04DegXWlx-uPocMIEmCb0eHJ0zKbNKYvpT2Nh5G7DX5CT3Z2T6R7rKy4wK6Vqmct8XsbeJ8LDsQzzVJ3kiZEmzRS3tpBpkRoFWsFzz7mTToGqdIkTRnnPbfKSrNdN7V8TagxAv89yq9BmMLwwfF546UDPG5kXPiJiWHNtezZyLIpxqYews3ON-6RxnzRPNbxMRD6Ofa4CF8edd2_jVo53Io929wNIl-6lS98nXRFJBkHQQ6oqKFd4UHXn0NnYqzdkgoFyb79NkDVYD2zhK0oEUhlhvGeG3tk4Iu8HKdSgBdC1Y2rfLG50jN5xrP-UR-RVkMpx4mBRgiFYpBFRK_K6sjKrV-rqrGMaBxFIFZdv_sdSviWPcKohePIdWW-vF34TDLq23CJrn27FVvcFQ7s_24b24HbnN8EMQ_0 |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGkAAJIRgMAgyMxBuyZufDTh67wtTCVqS1TH2zHNuFbCOpuhaJ_567fJQWoSHx0ofEbpzz5e6X3N3vCHkrUmXTWcKZULOcxdjIPQVHx7gH35IbACR5nSA7koMv8cdpMt0h_a4WBtMqW9vf2PTaWrdHDltpHs6L4nAswHdlSoCDQ8et4L39NqABhf0bhtOjjeLIph4ORjMc3lbONElexUWBdKFhWPOdoo_a8E41if-Wk7pVFsXfoOifGZUbLur4IXnQYkvaa5b_iOz4co_cOW2j53vkfvONjjalR4_JZa-kZrWs5tc_qQVvRqsZ7X8-H75nImNXxaWnxq6Wni5-h-OpK5rqEtpRHdC6yzj9fjbqMQEohY57Z2PWr85ZSH8YC1eu9_4JmRx_mPQHrG2-wKyUaslc4tM89D4SHt7QsGTVSR4ZaWIQtbWZjLPYKDAQnnvOnXQKrKaLnDDKe26jfbJbVqV_RqgxgAJ8klqF8MHwzPBZ5qUDk29kmvmAiE7m2rbE5Ngf40p3GWgXGvdJ4z5pHmtYTEDerefMG1qOG0cf4VauRyKldn2gWnzVrU7pTMLyQT8F0ueENk59HoWZE96J0IE-ByTqFEF3VatgZ-GPihsvnaxnben1P-cdgK6BPPAXHqhIIKsRpn4mGKgNA_Km00INBgGjPKb01epahxgox1ZQaUCeNlq5vnEAl4AJszggaktftySzfaYsvtWk46ACseLy-X_ez2tydzA5PdEnw9GnF-QenmnSKF-S3eVi5Q8A2i3zV_Wj-wssUkR- |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+autopsy+case+of+COVID-19-like+acute+respiratory+distress+syndrome+after+mRNA-1273+SARS-CoV-2+vaccination&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Yoshimura%2C+Yukihiro&rft.au=Sasaki%2C+Hiroaki&rft.au=Miyata%2C+Nobuyuki&rft.au=Miyazaki%2C+Kazuhito&rft.date=2022-08-01&rft.issn=1201-9712&rft.volume=121&rft.spage=98&rft.epage=101&rft_id=info:doi/10.1016%2Fj.ijid.2022.04.057&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ijid_2022_04_057 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon |